Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...

GlaxoSmithKline (GSK) has announced that Arexvy, its respiratory syncytial virus (RSV) vaccine, has received expanded ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that ...

Eisai and Biogen’s Supplemental Biologics License Application (sBLA) for Leqembi (lecanemab) subcutaneous autoinjector (SC-AI) has been accepted by the US FDA under Priority Review to treat early ...

Gilead has announced full results from its study of Trodelvy (sacituzumab govitecan) plus Keytruda (pembrolizumab) as a first ...

Sanofi has announced that its amlitelimab has shown positive results in the treatment of patients 12 years and older with ...

Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths ...

Prescient acquires Uptake, with a focus on exceptional client delivery and impact in the pharmaceutical and biotech industry ...

The Novo Nordisk Foundation has allocated up to 736m euros in funding to BioInnovation Institute (BII), a leading institute ...

Inizio Evoke has appointed Kristin Ryan as Executive Vice President (VP), AI Transformation & Acceleration.